MedPath

study on effectiveness of methyl prednisolon intratempanic injection in compared to dexametason indoenphatic hydrops and tinnitus cure in definite menier pationts

Phase 3
Conditions
Meniere.
Ménière disease
Registration Number
IRCT2015102912691N3
Lead Sponsor
Vice Chancellorfor Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
41
Inclusion Criteria

Patients between 18 and 80 years, did not respond to treatment salt restriction, diuretics and betahistine for three months
Exclusion criteria: Disease of neuromuscular system, diseases of the spinal cord and CNS disease of the middle ear, otitis media, conductive hearing loss, taking ototoxic, drug addiction, patients with a history of middle ear surgery, surgical intervention in the inner ear, patients by menier bilateral and perforation of the tympanic membrane and absence of systemic corticosteroid treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vertigo. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: Audiometery Test and questionnaire.
Secondary Outcome Measures
NameTimeMethod
Hearing. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: Audiometry Test.;Tinnitus. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath